Overview

Study to Assess Inhibition of Spore Production in Patients With C. Difficile Infections: Fidaxomicin Versus Vancomycin

Status:
Completed
Trial end date:
2014-12-15
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare number of vegetative cells and spores in stool over time for fidaxomicin or vancomycin in patients diagnosed with their first episode of C. difficile infection.
Phase:
Phase 4
Details
Lead Sponsor:
Hartford Hospital
Collaborator:
Optimer Pharmaceuticals LLC
Treatments:
Fidaxomicin
Vancomycin